ITMCTR2024000169尚未招募1 期
A self-controlled trial project treating patients with knee osteoarthritis using a nano-enabled Lidocaine delivery acupuncture needle(Lidocaine nd-Acu)
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 45 至 80（—）
- 性别
- All
入选标准
- •1) age from 45 to 80 years old;
- •2) patients meet the diagnostic criteria for knee osteoarthritis according to the 2014 National Institute for Health and Clinical Excellence criteria of the United Kingdom;
- •3) In recent 6 months, Kellgren and Lawrecne's radiological diagnostic criteria were in line with Grade I to Grade III;
- •4) The average severity of knee pain in the past week was =4 points (0 points representing no pain, 10 points representing extreme pain, a total of 11 scales);
- •5) male or female;
- •6) patients who signed informed consent and volunteer to participate in this project.
排除标准
- •1) patients with a history of knee replacement surgery;
- •2) knee pain caused by other diseases (e.g. joint loosening, infection, malignancy, autoimmune disease, trauma, etc.). Patients with acute and chronic periarticular synovitis, bursitis, ligamentitis and other soft tissue inflammation should be evaluated by doctors to decide whether to enter the group;
- •3) had undergone arthroscopy or intra-articular injection within 1 year;
- •4) pregnant or lactating women;
- •5) severe acute/chronic organic or mental illness;
- •6) coagulation disorders (such as hemophilia);
- •7) participated in other clinical studies in the past three months.
研究者
相似试验
已完成
不适用
Pilot study to establish the treatment of patients with frailty and sarcopenia using the device of promoting neural control of paravertebral muscleower back pain patients with frailty/sarcopenia, or having muscle weakness in their previous stageJPRN-UMIN000029803Fukuoka University Hospital8
招募中
不适用
Effect of breast oncoplastic reshaping on the long term cosmetic outcome after breast conservation surgery : A prospective randomised trial.Breast CancerACTRN12612000638831Kathryn Andrews316
已完成
3 期
A randomised, controlled clinical trial assessing the efficacy of;Lanreotide to halt disease progression in ADPKDpolycystic kidney disease100383601001965410029149Autosomal Dominant Polycystic Kidney DiseaseNL-OMON39497niversitair Medisch Centrum Groningen300
进行中（未招募）
不适用
To investigate the effect of Lanreotide on renal function decline in ADPKD patientsFirst, to demonstrate whether Lanreotide attenuates progression of the renal phenotype in ADPKD patients as measuredby change in rate of renal function decline and change in renal volume. Second, to demonstrate whether Lanreotidemodifies progression of the liver phenotype in the subset of ADPKD patients with moderate to severe polycystic liverdisease as measured by change in liver volume.MedDRA version: 14.1Level: LLTClassification code 10023433Term: Kidney polycysticSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2011-005017-37-NLDIPAK Consortium
已完成
不适用
Bladder Care Following Laparoscopy for Benign Non-Hysterectomy Gynaecological Conditions – A Randomised Controlled TrialPost-operative bladder care following laparoscopy for benign non-hysterectomy gynaecological conditionsRenal and Urogenital - Other renal and urogenital disordersACTRN12611000414910Associate Professor Jason Abbott866